• ქართული
  • English
  • Daiichi Sankyo, AstraZeneca sign $6.9 billion cancer drug deal

    AstraZeneca Plc and Japan’s Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi’s cancer drug trastuzumab deruxtecan.

    Market Quotes by TradingView